Wells Fargo’s Pear Therapeutics, Inc. Class A Common Stock PEAR Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2023
Q2
Sell
-14,441
Closed -$3.68K 7418
2023
Q1
$3.68K Buy
14,441
+10,122
+234% +$2.58K ﹤0.01% 5798
2022
Q4
$5.1K Buy
4,319
+2,059
+91% +$2.43K ﹤0.01% 5439
2022
Q3
$5K Buy
2,260
+2,029
+878% +$4.49K ﹤0.01% 5610
2022
Q2
$0 Buy
231
+19
+9% ﹤0.01% 7507
2022
Q1
$1K Buy
+212
New +$1K ﹤0.01% 6561